학술논문
Unexpected gastrointestinal toxicity from Docetaxel/Carboplatin/Erlotinib followed by maintenance Erlotinib treatment for newly diagnosed stage III/IV ovarian cancer, primary peritoneal, or fallopian tube cancer
Document Type
Correspondence
Source
In Gynecologic Oncology 1 May 2011 121(2):426-426
Subject
Language
ISSN
0090-8258